TBA Law Blog


Posted by: Azya Thornton on May 4, 2026

A $7.4 billion settlement with Purdue Pharma and its owners, the Sackler family, has taken effect, resolving years of litigation over their role in the opioid crisis and directing funds to states, communities and victims nationwide. Attorney General Jonathan Skrmetti announced in a press release that Tennessee is expected to receive approximately $122.4 million as part of the agreement, which follows a multistate investigation launched in 2016 and Tennessee’s 2018 lawsuit against Purdue. The settlement, reached after the U.S. Supreme Court invalidated key provisions of a prior deal in 2024, permanently bars the Sacklers from selling opioids in the United States and provides funding for addiction treatment, prevention and recovery efforts over the next 15 years. It also requires the release of millions of documents related to Purdue’s opioid business and transfers the company’s operations to a new entity, Knoa Pharma LLC, which will be subject to independent oversight.